Cellebrite DI Ltd. (CLBT) Earnings Call Transcripts
Cellebrite DI Ltd.'s Latest Earnings Call - June 10, 2026
In the Q2 2026 earnings call for Cellebrite DI Ltd. (CLBT:US), the company reported a revenue of $50 million, which was a 15% increase year-over-year, exceeding analyst expectations of $45 million. The earnings per share (EPS) came in at $0.30, beating the consensus estimate by $0.05. Management announced the general availability of their new AI-powered product, Genesis, which is expected to enhance operational efficiency for customers. Guidance for Q3 was raised, with projected revenue now between $55 million and $60 million, up from the previous estimate of $50 million to $55 million, signaling strong demand for their solutions.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $50M (beat) |
| EPS | $0.30 (beat) |
| Q3 Revenue Guidance | $55M - $60M (raised) |
| Customer Participation in Genesis | 800+ users (positive) |
| Year-over-Year Revenue Growth | 15% (positive) |
| Market Expansion | Broader customer base (positive) |
Guidance from management
Management raised Q3 revenue guidance to between $55 million and $60 million, reflecting strong demand for their AI-powered solutions and an optimistic outlook for continued growth.
What management said
Yes. We definitely have to -- we maintain all legal privacy and restriction of jurisdictions in all the geos that we operate in. And so the integrity of the evidence collection and the storage and access of that information, obviously, is it's highly sensitive and very critical. So all of our systems, whether you are on-prem or if you're using a cloud product and now increasingly as we use -- that is our differentiat...
It depends on the situation in a specific device. It's a combination, obviously. The software utilizes various hardware components inside our value fits to export a device. And it depends on, like it's very vendor specific. But generally, there is a significant combination of the hardware, and we are dependent on the hardware in those situations. So it's not purely software. And some of the hardware is for protection...
What analysts pressed on
Analysts expressed concerns about the increasing difficulty of data extraction as mobile OEMs improve their software security. There were questions regarding how Cellebrite plans to maintain its competitive edge in this evolving landscape.
Main topics on the call
- AI Product Launch — Cellebrite announced the general availability of its AI-powered product, Genesis, which aims to provide actionable insights to investigators. Management noted, "the early feedback we're getting from customers has been re...
- Revenue Growth — The company reported a revenue of $50 million for Q2 2026, a 15% increase year-over-year, surpassing analyst expectations of $45 million. This growth reflects strong demand for Cellebrite's expanded product offerings.
- Customer Base Expansion — Cellebrite is broadening its customer base beyond digital forensic labs to include a wider range of investigators and analysts within public safety organizations. Management stated, "the more we expand, the more we reach...
- Guidance Increase — Management raised Q3 revenue guidance to a range of $55 million to $60 million, up from the previous estimate of $50 million to $55 million. This adjustment reflects confidence in ongoing demand and product adoption.
Read the full Cellebrite DI Ltd. transcript (June 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Cellebrite DI Ltd.
Cellebrite DI Ltd. (CLBT) is a publicly listed company in the Software industry, within the Information Technology sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 26 calls on record spanning February 16, 2022 to August 13, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 26 Cellebrite DI Ltd. earnings call transcripts on record, spanning February 16, 2022 to August 13, 2026. Based on this history, Cellebrite DI Ltd. reports quarterly. The most recent call on file is dated August 13, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- CLBT
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Information Technology
- Industry
- Software
- Calls on record
- 26
- First call
- February 16, 2022
- Most recent
- August 13, 2026
- Reporting cadence
- quarterly